These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 23242137)
1. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Shao W; Zhang SZ; Tang M; Zhang XH; Zhou Z; Yin YQ; Zhou QB; Huang YY; Liu YJ; Wawrousek E; Chen T; Li SB; Xu M; Zhou JN; Hu G; Zhou JW Nature; 2013 Feb; 494(7435):90-4. PubMed ID: 23242137 [TBL] [Abstract][Full Text] [Related]
2. Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice. Qiu J; Yan Z; Tao K; Li Y; Li Y; Li J; Dong Y; Feng D; Chen H J Neuroinflammation; 2016 Oct; 13(1):263. PubMed ID: 27724964 [TBL] [Abstract][Full Text] [Related]
3. Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model. Zhang Y; Chen Y; Wu J; Manaenko A; Yang P; Tang J; Fu W; Zhang JH Stroke; 2015 Sep; 46(9):2637-46. PubMed ID: 26251254 [TBL] [Abstract][Full Text] [Related]
4. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes. Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997 [TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3. Zhu J; Hu Z; Han X; Wang D; Jiang Q; Ding J; Xiao M; Wang C; Lu M; Hu G Cell Death Differ; 2018 Nov; 25(11):2037-2049. PubMed ID: 29786071 [TBL] [Abstract][Full Text] [Related]
8. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration. Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292 [TBL] [Abstract][Full Text] [Related]
9. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a β-arrestin2-biased mechanism. Zhu J; Sun T; Zhang J; Liu Y; Wang D; Zhu H; Yao H; Ding J; Hu G; Lu M Brain Behav Immun; 2020 Nov; 90():259-271. PubMed ID: 32861720 [TBL] [Abstract][Full Text] [Related]
10. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons. Miller JA; Trout BR; Sullivan KA; Bialecki RA; Roberts RA; Tjalkens RB J Neurosci Res; 2011 Mar; 89(3):406-17. PubMed ID: 21259327 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis. Lu SZ; Wu Y; Guo YS; Liang PZ; Yin S; Yin YQ; Zhang XL; Liu YF; Wang HY; Xiao YC; Liang XM; Zhou JW J Exp Med; 2022 Sep; 219(9):. PubMed ID: 35877595 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor D2 on CD4 Liu Z; Zhai XR; Du ZS; Xu FF; Huang Y; Wang XQ; Qiu YH; Peng YP Brain Behav Immun; 2021 Nov; 98():110-121. PubMed ID: 34403737 [TBL] [Abstract][Full Text] [Related]
13. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Wei Y; Lu M; Mei M; Wang H; Han Z; Chen M; Yao H; Song N; Ding X; Ding J; Xiao M; Hu G Nat Commun; 2020 Feb; 11(1):941. PubMed ID: 32071304 [TBL] [Abstract][Full Text] [Related]
14. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Ousman SS; Tomooka BH; van Noort JM; Wawrousek EF; O'Connor KC; Hafler DA; Sobel RA; Robinson WH; Steinman L Nature; 2007 Jul; 448(7152):474-9. PubMed ID: 17568699 [TBL] [Abstract][Full Text] [Related]
15. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson's disease. Liu Y; Zhou Q; Tang M; Fu N; Shao W; Zhang S; Yin Y; Zeng R; Wang X; Hu G; Zhou J Neurobiol Aging; 2015 Apr; 36(4):1686-1691. PubMed ID: 25683516 [TBL] [Abstract][Full Text] [Related]
17. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration. Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation. Hwang CJ; Lee HP; Choi DY; Jeong HS; Kim TH; Lee TH; Kim YM; Moon DB; Park SS; Kim SY; Oh KW; Hwang DY; Han SB; Lee HJ; Hong JT Oncotarget; 2016 Jul; 7(30):46943-46958. PubMed ID: 27409674 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra. Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869 [TBL] [Abstract][Full Text] [Related]
20. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]